Arch Therapeutics Short Interest Ratio and Short Volume

-0.01 (-6.71 %)
(As of 09/17/2021 03:53 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume308,600 shs
Average Volume485,672 shs
Market Capitalization$22.73 million
P/E RatioN/A
Dividend YieldN/A

Arch Therapeutics (OTCMKTS:ARTH) Short Interest Data

Current Short Volume23,700 shares
Previous Short Volume173,800 shares
Change Vs. Previous Month-86.36%
Dollar Volume Sold Short$1,623.45
Short Interest Ratio / Days to Cover0.0
Last Record DateAugust, 31 2021
Outstanding Shares236,720,000 shares
Percentage of Shares Shorted0.01%
Today's Trading Volume308,600 shares
Average Trading Volume485,672 shares
Today's Volume Vs. Average-36.46%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Arch Therapeutics ?

Sign up to receive the latest short interest report for Arch Therapeutics and its competitors with MarketBeat's FREE newsletter.

Arch Therapeutics (OTCMKTS:ARTH) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202123,700 shares $1,623.45 -86.4%N/A0 $0.07
8/13/2021173,800 shares $16,041.74 -6.9%N/A0.2 $0.09
7/30/2021186,600 shares $16,794.00 -3.1%N/A0.4 $0.09
7/15/2021192,600 shares $17,334.00 +11.9%N/A0.3 $0.09
6/30/2021172,100 shares $16,315.08 -9.1%N/A0.2 $0.09
6/15/2021189,400 shares $18,475.97 -18.0%N/A0.2 $0.10
5/28/2021230,900 shares $23,090.00 -15.9%N/A0.4 $0.10
5/14/2021274,700 shares $33,650.75 -25.6%N/A1.1 $0.12
4/30/2021369,000 shares $47,896.20 -5.5%N/A0.5 $0.13
4/15/2021390,500 shares $44,907.50 -56.0%N/A0.4 $0.12
3/31/2021887,000 shares $132,606.50 +72.7%N/A3.2 $0.15
3/15/2021513,500 shares $89,297.65 +79.7%N/A1 $0.17
2/26/2021285,700 shares $47,997.60 -13.7%N/A0.3 $0.17
2/12/2021331,100 shares $56,287.00 -8.9%N/A0.8 $0.17
1/29/2021363,600 shares $61,812.00 +12.9%N/A1.1 $0.17
1/15/2021379,500 shares $63,376.50 +10.5%N/A0.6 $0.17
12/31/2020313,300 shares $43,862.00 -17.4%N/A0.4 $0.14
12/15/2020379,500 shares $60,644.10 +10.5%N/A0.6 $0.16
11/30/2020343,300 shares $56,987.80 -1.6%N/A2.1 $0.17
11/15/2020348,800 shares $60,168.00 -5.0%N/A1.7 $0.17
10/30/2020367,100 shares $61,305.70 -26.5%N/A0.8 $0.17
10/15/2020499,400 shares $87,395.00 -49.9%N/A2.2 $0.18
9/30/2020996,400 shares $172,576.48 +75.7%N/A1.5 $0.17
9/15/2020567,000 shares $98,601.30 -37.7%N/A0.8 $0.17
8/31/2020910,300 shares $151,838.04 -11.6%N/A1.3 $0.17

Arch Therapeutics (OTCMKTS:ARTH) Short Interest FAQ

speech bubbles
speech bubbles

What is Arch Therapeutics' current short interest?

Short interest is the volume of Arch Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 31st, traders have sold 23,700 shares of ARTH short. Learn More on Arch Therapeutics' current short interest.

Is Arch Therapeutics' short interest increasing or decreasing?

Arch Therapeutics saw a decrease in short interest in August. As of August 31st, there was short interest totaling 23,700 shares, a decrease of 86.4% from the previous total of 173,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Arch Therapeutics' short interest compare to its competitors?

0.00% of Arch Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Arch Therapeutics: Assure Holdings Corp. (0.00%), LENSAR, Inc. (2.17%), RenovaCare, Inc. (0.00%), Femasys Inc. (0.25%), Avinger, Inc. (1.62%), Hancock Jaffe Laboratories, Inc. (6.44%), Spectral Medical Inc. (0.00%), Delcath Systems, Inc. (0.00%), NeuroMetrix, Inc. (0.00%), and STRATA Skin Sciences, Inc. (0.60%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short Arch Therapeutics stock?

Short selling ARTH is an investing strategy that aims to generate trading profit from Arch Therapeutics as its price is falling. Arch Therapeutics' stock is trading down $0.01 today. To short Arch Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Arch Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Arch Therapeutics?

A short squeeze for Arch Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARTH, which in turn drives the price of the stock up even further.

How often is Arch Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARTH, twice per month. The most recent reporting period available is August, 31 2021.

This page was last updated on 9/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.